A Trial to Investigate Recovery From COVID-19 With C21 in Adult Subjects
NCT04880642
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
272
Enrollment
INDUSTRY
Sponsor class
Conditions
COVID-19
Interventions
DRUG:
C21
DRUG:
Placebo
Sponsor
Vicore Pharma AB